rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
2
|
pubmed:dateCreated |
2000-7-21
|
pubmed:abstractText |
A 54-year-old patient with a Stage IVb adenocarcinoma of the cervix was treated with combination chemotherapy. This regimen consisted of intravenous cisplatin (70 mg/m2) and aclacinomycin A (30 mg/m2) on Day 1, followed by mitomycin C (5 mg/m2) on Day 2 and 3. A pathologically complete response was achieved by this regimen. The patient is well and has been free of symptoms for 66 months.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
1341-8076
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
26
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
133-6
|
pubmed:dateRevised |
2006-4-24
|
pubmed:meshHeading |
pubmed-meshheading:10870306-Adenocarcinoma,
pubmed-meshheading:10870306-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:10870306-Cisplatin,
pubmed-meshheading:10870306-Doxorubicin,
pubmed-meshheading:10870306-Drug Administration Schedule,
pubmed-meshheading:10870306-Female,
pubmed-meshheading:10870306-Humans,
pubmed-meshheading:10870306-Middle Aged,
pubmed-meshheading:10870306-Mitomycin,
pubmed-meshheading:10870306-Neoplasm Staging,
pubmed-meshheading:10870306-Uterine Cervical Neoplasms
|
pubmed:year |
2000
|
pubmed:articleTitle |
A case of stage-IVb cervical adenocarcinoma successfully treated by combination chemotherapy: case report.
|
pubmed:affiliation |
Department of Obstetrics and Gynecology, Sapporo Medical University, School of Medicine, Japan.
|
pubmed:publicationType |
Journal Article,
Case Reports
|